Supplementary Figure S20 from Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure S20 shows shows bar graphs of expression of SEZ6 and B7H3 across SCLC tumors in Cohort C.
Authors: Avanish Mishra, Catherine B. Meador, Kruthika Kikkeri, Quinn Cunneely, Maoxuan Lin, Thomas J. Carmona-LaSalle, Shih-Bo Huang, Remy Bell, Victor Putaturo, Weikun Xia, Joyce H. Liang, Jacy Fang, Sarah San Vicente, Caroline E. Zielinski, Subba R. Digumarthy, Yin P. Hung, Beow Y. Yeap, Jon F. Edd, Michael S. Lawrence, Moshe Sade-Feldman, Debattama R. Sen, Mehmet Toner, Shyamala Maheswaran, Justin F. Gainor, Daniel A. Haber
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7165185796
Cites:
Cited by:
Related to: